Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INFLIXIMAB-DYYB Cause Covid-19? 2,262 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 2,262 reports of Covid-19 have been filed in association with INFLIXIMAB-DYYB (ZYMFENTRA). This represents 8.8% of all adverse event reports for INFLIXIMAB-DYYB.

2,262
Reports of Covid-19 with INFLIXIMAB-DYYB
8.8%
of all INFLIXIMAB-DYYB reports
42
Deaths
653
Hospitalizations

How Dangerous Is Covid-19 From INFLIXIMAB-DYYB?

Of the 2,262 reports, 42 (1.9%) resulted in death, 653 (28.9%) required hospitalization, and 13 (0.6%) were considered life-threatening.

Is Covid-19 Listed in the Official Label?

Yes, Covid-19 is listed as a known adverse reaction in the official FDA drug label for INFLIXIMAB-DYYB.

What Other Side Effects Does INFLIXIMAB-DYYB Cause?

Off label use (14,256) Condition aggravated (10,275) Intentional product use issue (7,549) Inappropriate schedule of product administration (5,977) Arthralgia (4,615) Drug ineffective (3,112) Fatigue (3,111) Weight increased (2,848) Malaise (2,766) Weight decreased (2,703)

What Other Drugs Cause Covid-19?

NIRMATRELVIR\RITONAVIR (22,066) OCRELIZUMAB (11,454) ADALIMUMAB (9,138) DUPILUMAB (6,986) RITUXIMAB (6,301) LENALIDOMIDE (6,223) TOFACITINIB (4,926) SECUKINUMAB (3,871) INFLIXIMAB (3,698) TACROLIMUS (3,201)

Which INFLIXIMAB-DYYB Alternatives Have Lower Covid-19 Risk?

INFLIXIMAB-DYYB vs INFLIXIMAB-QBTX INFLIXIMAB-DYYB vs INFLIXIMAB, RECOMBINANT INFLIXIMAB-DYYB vs INFLUENZA A VIRUS A/CALIFORNIA/7/2009 LIVE ANTIGEN\INFLUENZA A VIRUS A/TEXAS/50/2012 LIVE ANTIGEN\INFLUENZA B VIRUS B/BRISBANE/60/2008 LIVE ANTIGEN\INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 LIVE ANTIGEN INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE QUADRIVALENT TYPE A+B

Related Pages

INFLIXIMAB-DYYB Full Profile All Covid-19 Reports All Drugs Causing Covid-19 INFLIXIMAB-DYYB Demographics